Physician profile
Alin Cheran
NPI 1992156483
$5,798.40
in general payments reported to CMS, 2019-2025
9 companies · $3,349 in 2025
The $3,349 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $452 · 2021: $15.58 · 2022: $25.99 · 2023: $30.32 · 2024: $1,608 · 2025: $3,349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,731 · Food and Beverage: $2,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,730.84 |
| Food and Beverage | $2,255.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $4,475.33 | 2024-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Edwards Lifesciences Corporation | $329.83 | 2023-2025 | Konect Resilia, Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia |
| Medical Device Business Services, INC. | $305.00 | 2020 | |
| Abiomed | $207.50 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $188.40 | 2019 | |
| Acell, INC. | $180.01 | 2019-2020 | |
| Z-Medica, LLC | $74.17 | 2019 | |
| Ethicon US, LLC | $22.58 | 2020 | |
| Janssen Pharmaceuticals, INC | $15.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alin Cheran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.